PI3Kγ mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Cell

• Publication date

  2011-06-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccr.2011.05.005PMID 21665152PMCID PMC3170773
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PI3K inhibition in inflammation: Toward tailored therapies for specific diseases

  2010cited by this paper
• Phosphoinositide signalling in cancer: beyond PI3K and PTEN

  2010cited by this paper
• KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

  2010influential reference
• Kaposi's sarcoma and its associated herpesvirus

  2010influential reference
• mTOR signaling and drug development in cancer

  2010cited by this paper
• Small molecule inhibitors of phosphoinositide 3-kinase (PI3K) delta and gamma.

  2009cited by this paper
• mTOR signaling at a glance

  2009cited by this paper
• Kaposi’s sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression

  2008cited by this paper
• Phosphoinositide 3-kinase signalling in the vascular system.

  2008cited by this paper
• Defining the role of mTOR in cancer.

  2007cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?

  2006cited by this paper
• The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

  2006cited by this paper
• The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

  2006cited by this paper
• mTOR and cancer: insights into a complex relationship

  2006cited by this paper
• PI3Kγ inhibition: towards an 'aspirin of the 21st century'?

  2006cited by this paper
• Signalling by PI3K isoforms: insights from gene-targeted mice.

  2005cited by this paper
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase

  2004cited by this paper
• Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor.

  2004cited by this paper
• Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

  2003cited by this paper
• Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes.

  2003influential reference
• Polyoma virus middle T antigen and its role in identifying cancer-related molecules

  2002cited by this paper
• Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

  2000cited by this paper
• Transgenic Expression of the Chemokine Receptor Encoded by Human Herpesvirus 8 Induces an Angioproliferative Disease Resembling Kaposi's Sarcoma

  2000cited by this paper
• Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation

  2000cited by this paper
• Linkage of G Protein-Coupled Receptors to the MAPK Signaling Pathway Through PI 3-Kinase γ

  1997cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper

• Enfermedad de Kaposi

  2026cites this paper
• Targeting PI3Kγ in cancer

  2025cites this paper
• Targeting PI3K in Cancer Treatment: A Comprehensive Review with Insights from Clinical Outcomes.

  2025cites this paper
• The Origin of Kaposi's Sarcoma and Other KSHV‐Associated Sarcomas

  2025cites this paper
• Maladie de Kaposi

  2025cites this paper
• Phosphoinositide dynamics in virus-associated malignancies.

  2025cites this paper
• Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature

  2024cites this paper
• Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review.

  2023cites this paper
• Roles of phosphatidyl inositol 3 kinase gamma (PI3Kγ) in respiratory diseases

  2021cites this paper
• Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection

  2021cites this paper
• Cancers associated with human gammaherpesviruses

  2021cites this paper
• Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations.

  2021cites this paper
• Regulation of Kaposi’s Sarcoma-Associated Herpesvirus Biology by Host Molecular Chaperones

  2020cites this paper
• CMAR_A_250171 2641..2651

  2020cites this paper
• LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter

  2020cites this paper
• Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer

  2020cites this paper
• G Protein‐Coupled receptors and heterotrimeric G proteins as cancer drivers

  2020cites this paper
• VDR agonists down regulate PI3K/Akt/mTOR axis and trigger autophagy in Kaposi's sarcoma cells

  2019cites this paper
• Kaposi sarcoma-associated herpesvirus miRNAs suppress CASTOR1-mediated mTORC1 inhibition to promote tumorigenesis.

  2019cites this paper
• In Vivo Models of Oncoproteins Encoded by Kaposi’s Sarcoma-Associated Herpesvirus

  2019cites this paper
• Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy

  2019cites this paper
• Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

  2018cites this paper
• Corrections

  2018cites this paper
• Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients

  2018cites this paper
• Cellular and viral oncogenes: the key to unlocking unknowns of Kaposi’s sarcoma-associated herpesvirus pathogenesis

  2018cites this paper
• Rhadinoviral interferon regulatory factor homologues

  2017cites this paper
• Notch signaling via regulation of RB and p-AKT but not PIK3CG contributes to MIA PaCa-2 cell growth and migration to affect pancreatic carcinogenesis

  2017cites this paper
• Epidemiological aspects and origin of KSHV

  2017cites this paper
• Genome-scale transcriptional analysis reveals key genes associated with the development of type II diabetes in mice.

  2017cites this paper
• Constitutive activation of T cells by γ2-herpesviral GPCR through the interaction with cellular CXCR4.

  2017cites this paper
• Kaposi sarcoma herpesvirus pathogenesis

  2017cites this paper
• Gβγ Pathways in Cell Polarity and Migration Linked to Oncogenic GPCR Signaling: Potential Relevance in Tumor Microenvironment

  2016cites this paper
• Activation of the phosphatidylinositol 3-kinase/Akt pathway by viral interferon regulatory factor 2 of Kaposi's sarcoma-associated herpesvirus.

  2016cites this paper
• KSHV-Mediated Angiogenesis in Tumor Progression

  2016cites this paper
• Hijacking GPCRs by viral pathogens and tumor.

  2016cites this paper
• Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi’s Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes

  2016cites this paper
• Molecular Biology of KSHV Lytic Reactivation

  2015cites this paper
• Glycosylation of KSHV Encoded vGPCR Functions in Its Signaling and Tumorigenicity

  2015cites this paper
• The Great Escape

  2015cites this paper
• Phosphoproteomic Analysis of KSHV-Infected Cells Reveals Roles of ORF45-Activated RSK during Lytic Replication

  2015cites this paper
• Stat1 stimulates cap-independent mRNA translation to inhibit cell proliferation and promote survival in response to antitumor drugs

  2015cites this paper
• A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling

  2015cites this paper
• Virus-encoded 7 transmembrane receptors.

  2015cites this paper
• Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

  2015cites this paper
• Herpesviral G Protein-Coupled Receptors Activate NFAT to Induce Tumor Formation via Inhibiting the SERCA Calcium ATPase

  2015cites this paper
• The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity

  2015influential citation
• Kaposi’s sarcoma-associated herpesvirus G-protein coupled receptor activates the canonical Wnt/β-catenin signaling pathway

  2014cites this paper
• vGPCR, The Great Escape

  2014cites this paper
• Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?

  2014cites this paper
• Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway

  2014cites this paper
• YGLF motif in the Kaposi sarcoma herpes virus G-protein-coupled receptor adjusts NF-κB activation and paracrine actions

  2014cites this paper
• Design and synthesis of a novel series of N,4-diphenylpyrimidin-2-amine derivatives as potent and selective PI3Kγ inhibitors

  2014cites this paper
• IKK epsilon kinase is crucial for viral G protein-coupled receptor tumorigenesis

  2013cites this paper
• HIV-1 Tat Promotes Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI3K/PTEN/AKT/GSK-3β Signaling Pathway

  2013cites this paper
• AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV

  2013cites this paper
• Review of latent and lytic phase biomarkers in Kaposi's sarcoma.

  2013cites this paper
• Molecular determinants of PI3Kγ-mediated activation downstream of G-protein–coupled receptors (GPCRs)

  2013cites this paper
• Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

  2013cites this paper
• Small and large-scale gene regulation in Kaposi's Sarcoma-associated Herpesvirus

  2013cites this paper
• Modulation of Autophagy-Like Processes by Tumor Viruses

  2012cites this paper
• Calming down T cell acute leukemia.

  2012cites this paper
• A selective inhibitor reveals PI3Kγ dependence of T(H)17 cell differentiation.

  2012cites this paper
• PI3K: A potential therapeutic target for cancer

  2012cites this paper
• HIV-1 Tat Promotes Kaposi ’ s Sarcoma-Associated Herpesvirus ( KSHV ) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI 3 K / PTEN / AKT / GSK-3 b Signaling Pathway

  2012cites this paper
• Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors.

  2012cites this paper
• PI3K keeps the balance between metabolism and cancer.

  2012cites this paper
• Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.

  2012cites this paper
• The unsulfated extracellular N-terminus of vGPCR reduces the tumorigenicity of hGRO-α in nude mice

  2012cites this paper
• Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma

  2012cites this paper
• Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma

  2012cites this paper
• Modulation of Immune System by Kaposi’s Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies

  2012cites this paper
• JAK-mutant myeloproliferative neoplasms.

  2012cites this paper
• Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside

  2011cites this paper